PuSH - Publikationsserver des Helmholtz Zentrums München

Bunz, M.* ; Eisele, M.* ; Hu, D.* ; Ritter, M.* ; Kammerloher, J. ; Lampl, S. ; Schindler, M.*

CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.

Front. Cell. Infect. Microbiol. 14:1338606 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The tetraspanin CD81 is one of the main entry receptors for Hepatitis C virus, which is a major causative agent to develop liver cirrhosis and hepatocellular carcinoma (HCC). Here, we identify CD81 as one of few surface proteins that are downregulated in HCV expressing hepatoma cells, discovering a functional role of CD81 beyond mediating HCV entry. CD81 was downregulated at the mRNA level in hepatoma cells that replicate HCV. Kinetics of HCV expression were increased in CD81-knockout cells and accompanied by enhanced cellular growth. Furthermore, loss of CD81 compensated for inhibition of pro-survival TBK1-signaling in HCV expressing cells. Analysis of functional phenotypes that could be associated with pro-survival signaling revealed that CD81 is a negative regulator of NF-κB. Interaction of the NF-κB subunits p50 and p65 was increased in cells lacking CD81. Similarly, we witnessed an overall increase in the total levels of phosphorylated and cellular p65 upon CD81-knockout in hepatoma cells. Finally, translocation of p65 in CD81-negative hepatoma cells was markedly induced upon stimulation with TNFα or PMA. Altogether, CD81 emerges as a regulator of pro-survival NF-κB signaling. Considering the important and established role of NF-κB for HCV replication and tumorigenesis, the downregulation of CD81 by HCV and the associated increase in NF-κB signaling might be relevant for viral persistence and chronic infection.
Impact Factor
Scopus SNIP
Altmetric
4.600
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cd81 ; Hcc ; Nf-κb ; Hepatitis C Virus ; Hepatocellular Carcinoma ; Tetraspanin; Nuclear-factor; Hepatocellular-carcinoma; Superinfection Exclusion; Protein-kinase; Surface Cd4; Core; Activation; Receptor; Liver; Interferon
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2235-2988
e-ISSN 2235-2988
Quellenangaben Band: 14, Heft: , Seiten: , Artikelnummer: 1338606 Supplement: ,
Verlag Frontiers
Verlagsort Lausanne
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-006
Förderungen University Hospital Tubingen, Medical Faculty
DFG German Research Foundation
Scopus ID 85184930755
PubMed ID 38357447
Erfassungsdatum 2024-05-03